4/10/2014 6:08:18 AM
PARIS/ZURICH, April 10 (Reuters) - France's competition authority is investigating drugmakers Roche and Novartis on suspicion they were involved in anti-competitive practices in relation to eye disease treatments, the companies said on Thursday.
This is the second time in as many months that the Swiss drugmakers have faced regulatory scrutiny over treatments for wet age-related macular degeneration (AMD)- a leading cause of blindness among the elderly.
Help employers find you! Check out all the jobs and post your resume.
comments powered by